Michael F. Huang

Sr. VP of Clinical Development at Soleno Therapeutics · 3 reported transactions in 1 company · latest report May 18, 2026

Their trades


Soleno TherapeuticsSLNO	Returned to company — · 39,823 shares	May 18, 2026
Soleno TherapeuticsSLNO	Share award — · 10,400 shares	Jan 21, 2026
Soleno TherapeuticsSLNO	Shares withheld for tax $40.6K · 812 shares	Dec 15, 2025

May 18, 2026 · SLNO

39,823

Jan 21, 2026 · SLNO

10,400

Shares withheld for taxSoleno Therapeutics

Dec 15, 2025 · SLNO

$40.6K

3 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.